Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 15, 2000Journal of VirologyOpen Access

Prophylactic and Therapeutic Benefits of Short-Term 9-2-( R )-(Phosphonomethoxy)PropylAdenine (PMPA) Administration to Newborn Macaques following Oral Inoculation with Simian Immunodeficiency Virus with Reduced Susceptibility to PMPA

View Full Paper
Ask AI
Bookmark
Share

Authors

KRKoen K. A. Van RompayUniversity of California, DavisMMMichael D. MillerUniversity of ArizonaMMMarta L. MarthasOregon National Primate Research Center

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Rompay et al. (2000) studied this question.

synapsesocial.com/papers/6a70902826770c2b8de09c2ehttps://doi.org/10.1128/jvi.74.4.1767-1774.2000
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Acute Human Immunodeficiency Virus Type 1 Infection1998 · 729 citations
  2. 2Transmission of zidovudine-resistant HIV-1 through heterosexual contacts1994 · 39 citations
  3. 3Simian immunodeficiency virus (SIV) infection of infant rhesus macaques as a model to test antiretroviral drug prophylaxis and therapy: oral 3'-azido-3'-deoxythymidine prevents SIV infection1992 · 98 citations
  4. 4Primary Infection with Zidovudine-Resistant Human Immunodeficiency Virus Type 11993 · 245 citations
  5. 5Maternal Virus Load during Pregnancy and Mother-to-Child Transmission of Human Immunodeficiency Virus Type 1: The French Perinatal Cohort Studies1997 · 158 citations